Abstract
BackgroundTNF inhibitors are effective in treating spondyloarthritis (SpA). However, anti-drug antibodies (ADA) may be responsible for decreased efficacy. Methotrexate reduces adalimumab immunogenicity in rheumatoid arthritis (1).ObjectivesThe aim of the study...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have